Web13 apr. 2024 · Presentations highlight data from across all oncology pipeline programsMOUNTAIN VIEW, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage ... WebIGM Financial (IGM) will release its next earnings report on May 5, 2024. In the last quarter IGM Financial reported C$0.864 EPS in relation to C$0.94 expected by the market.
Investor Relations - IGM Biosciences
Web5 apr. 2024 · National Bank Financial also issued estimates for IGM Financial’s Q2 2024 earnings at $0.91 EPS, Q3 2024 earnings at $0.96 EPS and Q4 2024 earnings at … WebAction IGM Financial Inc. avec prévision des dividendes et des rendements 2024, 2024. Historique des dates de détachement et versement. RENDEMENT BOURSE. Chercher une action ... Price Earning Ratio . 11.07 Payout Ratio . 61.98% ... cryptsetup initramfs
IGM Financial Inc. Forecasted to Post Q1 2024 Earnings of $0.83 …
Web8 aug. 2024 · IGM Biosciences missed estimated earnings by 41.49%, reporting an EPS of $-1.33 versus an estimate of $-0.94. Revenue was up $366 thousand from the same period last year. Past Earnings Performance Last quarter the company beat on EPS by $0.08 which was followed by a 5.34% increase in the share price the next day. Web8 aug. 2024 · IGM Biosciences missed estimated earnings by 41.49%, reporting an EPS of $-1.33 versus an estimate of $-0.94. Revenue was up $366 thousand from the same … Web31 mrt. 2024 · IGM-8444 (DR5) Clinical development of IGM-8444. IGM continues to advance the clinical development of IGM-8444, the Company’s IgM DR5 agonist, in an … cryptsetup format disk